Health Condition 1: B180- Chronic viral hepatitis B with delta-agent
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Nanavati Max Institute of Liver Intestine and Pancreas Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1 Participants willing and able to provide informed consent prior to any study specific procedures being performed 2 Men and women 18 years of age or older inclusive based on the date of the screening visit 3 Patients with chronic hepatitis B on treatment with NUCs with undetectable HBV DNA levels for atleast 1 year OR Patients with Chronic Hepatitis B not on treatment with NUCs
Exclusion criteria
Exclusion criteria: 1 Liver cirrhosis 2 Undetectable levels of HBV DNA Quantitative for less than a year in patients who are on NUCs 3 Presence of HIV HCV or HDV on Medical history which might influence HBV Progression 4 Evidence of Hepatocellular Carcinoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study will evaluate HBV RNA levels in patients with varying HBsAg quantitative levels to identify the subset of patients with low HBsAg less than 100 IU per mL and undetectable HBV RNA.Timepoint: The study will evaluate HBV RNA levels in patients with varying HBsAg quantitative levels to identify the subset of patients with low HBsAg less than 100 IU per mL and undetectable HBV RNA. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Samir R Shah
Nanavati Max Institute of Liver Intestine and Pancreas Sciences
Outcome results
None listed